Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing

Blood Cells, Molecules, and Diseases

Volumn 52, Issue 1, 2014, Pages 35-45

  Zhang, Xu ^a   Zhang, Wei ^a   Ma, Shwu Fan ^b   Miasniakova, Galina ^c   Sergueeva, Adelina ^d   Ammosova, Tatiana ^e   Xu, Min ^e   Nekhai, Sergei ^e   Nourai, Mehdi ^e   Wade, Michael S ^a   Prchal, Josef T ^f,g   Garcia, Joe G N ^a   Machado, Roberto F ^a   Gordeuk, Victor R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Chuvash Republic Clinical Hospital 2   (Russian Federation)

^d Cheboksary Children's Hospital   (Russian Federation)

^e HOWARD UNIVERSITY   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF UTAH   (United States)

Author keywords

Chuvash polycythemia; Gene expression; Hypoxia inducible factor; Hypoxia sensing; Iron deficiency; VHL

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IRON REGULATORY FACTOR; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CARBOHYDRATE METABOLISM; CELL PROLIFERATION; CHUVASH POLYCYTHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; FERRITIN BLOOD LEVEL; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; GENOTYPE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IRON DEFICIENCY; LIPID METABOLISM; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHLEBOTOMY; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN STABILITY; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; WILD TYPE;

CHUVASH POLYCYTHEMIA; GENE EXPRESSION; HYPOXIA INDUCIBLE FACTOR; HYPOXIA-SENSING; IRON DEFICIENCY; VHL;

ANEMIA, IRON-DEFICIENCY; ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD GLUCOSE; GENE EXPRESSION REGULATION; HOMOZYGOTE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNITY, INNATE; INSULIN; IRON; LEUKOCYTES, MONONUCLEAR; PHLEBOTOMY; POLYCYTHEMIA; PROTEIN STABILITY; SIGNAL TRANSDUCTION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84888368132     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2013.07.016     Document Type: Article

References (60)

1. Semenza G.L. Hypoxia-inducible factors in physiology and medicine. Cell 2012, 148:399-408.
2. Bothwell T., Charlton R.W., Cook J.D., Finch C.A. Iron Metabolism in Man 1979, Blackwell Scientific Publications, Oxford.
3. Richalet J.P., Larmignat P., Poitrine E., Letournel M., Canoui-Poitrine F. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am. J. Respir. Crit. Care Med. 2012, 185:192-198.
4. Smith T.G., Balanos G.M., Croft Q.P., et al. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J. Physiol. 2008, 586:5999-6005.
5. Bailey D.M., Bartsch P., Knauth M., Baumgartner R.W. Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological. Cell. Mol. Life Sci. 2009, 66:3583-3594.
6. Martin D.S., Ince C., Goedhart P., Levett D.Z., Grocott M.P. Abnormal blood flow in the sublingual microcirculation at high altitude. Eur. J. Appl. Physiol. 2009, 106:473-478.
7. Scrase E., Laverty A., Gavlak J.C., et al. The Young Everest Study: effects of hypoxia at high altitude on cardiorespiratory function and general well-being in healthy children. Arch. Dis. Child. 2009, 94:621-626.
8. Manalo D.J., Rowan A., Lavoie T., et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005, 105:659-669.
9. Yuan G., Khan S.A., Luo W., et al. Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J. Cell. Physiol. 2011, 226:2925-2933.
10. Chan D.A., Sutphin P.D., Denko N.C., Giaccia A.J. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 2002, 277:40112-40117.
11. Park S.S., Bae I., Lee Y.J. Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron. J. Cell. Biochem. 2008, 103:1989-1998.
12. Collins J.F., Franck C.A., Kowdley K.V., Ghishan F.K. Identification of differentially expressed genes in response to dietary iron deprivation in rat duodenum. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G964-G971.
13. Fry M.M., Kirk C.A., Liggett J.L., et al. Changes in hepatic gene expression in dogs with experimentally induced nutritional iron deficiency. Vet. Clin. Pathol. 2009, 38:13-19.
14. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., Simon M.C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 2003, 23:9361-9374.
15. Karlovich C., Duchateau-Nguyen G., Johnson A., et al. A longitudinal study of gene expression in healthy individuals. BMC Med. Genomics 2009, 2:33.
16. O'Rourke J.A., Nelson R.T., Grant D., et al. Integrating microarray analysis and the soybean genome to understand the soybeans iron deficiency response. BMC Genomics 2009, 10:376.
17. Kaput J., Rodriguez R.L. Nutritional genomics: the next frontier in the postgenomic era. Physiol. Genomics 2004, 16:166-177.
18. Polyakova L. Familial erythrocytosis among inhabitants of the Chuvash ASSR. Problemi Gematologii I perelivaniya Krovi 1974, 10:30-36.
19. Ang S.O., Chen H., Hirota K., et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat. Genet. 2002, 32:614-621.
20. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
21. Minamishima Y.A., Kaelin W.G. Reactivation of hepatic EPO synthesis in mice after PHD loss. Science 2010, 329:407.
22. Hickey M.M., Lam J.C., Bezman N.A., Rathmell W.K., Simon M.C. Von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis. J. Clin. Invest. 2007, 117:3879-3889.
23. Rankin E.B., Rha J., Unger T.L., et al. Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 2008, 27:5354-5358.
24. Sanchez M., Galy B., Muckenthaler M.U., Hentze M.W. Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency. Nat. Struct. Mol. Biol. 2007, 14:420-426.
25. Bushuev V.I., Miasnikova G.Y., Sergueeva A.I., et al. Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica 2006, 91:744-749.
26. Gordeuk V.R., Sergueeva A.I., Miasnikova G.Y., et al. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 2004, 103:3924-3932.
27. Langmead B., Salzberg S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 2012, 9:357-359.
28. Sherry S.T., Ward M.H., Kholodov M., et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001, 29:308-311.
29. Borevitz J.O., Liang D., Plouffe D., et al. Large-scale identification of single-feature polymorphisms in complex genomes. Genome Res. 2003, 13:513-523.
30. Irizarry R.A., Hobbs B., Collin F., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
31. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5116-5121.
32. Anderson M. Permutation tests for univariate or multivariate analysis of variance and regression. Can. J. Fish. Aquat. Sci. 2001, 58:626-639.
33. Bertout J.A., Majmundar A.J., Gordan J.D., et al. HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14391-14396.
34. Benita Y., Kikuchi H., Smith A.D., et al. An integrative genomics approach identifies hypoxia inducible factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res. 2009, 37:4587-4602.
35. Nagao K., Oka K. HIF-2 directly activates CD82 gene expression in endothelial cells. Biochem. Biophys. Res. Commun. 2011, 407:260-265.
36. Vastrik I., D'Eustachio P., Schmidt E., et al. Reactome: a knowledge base of biologic pathways and processes. Genome Biol. 2007, 8:R39.
37. Keller H., Dreyer C., Medin J., et al. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:2160-2164.
38. Grant S.F., Thorleifsson G., Reynisdottir I., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 2006, 38:320-323.
39. Niu X., Miasnikova G.Y., Sergueeva A.I., et al. Altered cytokine profiles in patients with Chuvash polycythemia. Am. J. Hematol. 2009, 84:74-78.
40. Liu L., Zeng M., Stamler J.S. Hemoglobin induction in mouse macrophages. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6643-6647.
41. Grek C.L., Newton D.A., Spyropoulos D.D., Baatz J.E. Hypoxia up-regulates expression of hemoglobin in alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 2011, 44:439-447.
42. Zimmer M., Lamb J., Ebert B.L., et al. The connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2. Cancer Res. 2010, 70:3071-3079.
43. McClain D.A., Abuelgasim K.A., Nouraie M., et al. Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism. J. Mol. Med. 2013, 91:59-67.
44. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
45. Gautier E.L., Shay T., Miller J., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128.
46. Vaquero A.R., Ferreira N.E., Omae S.V., et al. Using gene-network landscape to dissect genotype effects of TCF7L2 genetic variant on diabetes and cardiovascular risk. Physiol. Genomics 2012, 44:903-914.
47. Pinaire J.A., Reifel-Miller A. Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome. PPAR Res. 2007, 2007:94156.
48. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
49. Semenza G.L. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin. Cancer Biol. 2009, 19:12-16.
50. Kim J.W., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3:177-185.
51. Regula K.M., Ens K., Kirshenbaum L.A. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ. Res. 2002, 91:226-231.
52. Verschoor M.L., Wilson L.A., Verschoor C.P., Singh G. Ets-1 regulates energy metabolism in cancer cells. PLoS One 2010, 5:e13565.
53. Hitosugi T., Fan J., Chung T.W., et al. Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol. Cell 2011, 44:864-877.
54. Chen G., Wang H., Miller C.T., et al. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J. Pathol. 2004, 202:321-329.
55. Zha X., Wang F., Wang Y., et al. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res. 2011, 71:13-18.
56. Wang R., Green D.R. Metabolic checkpoints in activated T cells. Nat. Immunol. 2012, 13:907-915.
57. Mole D.R., Blancher C., Copley R.R., et al. Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J. Biol. Chem. 2009, 284:16767-16775.
58. Grundy S.M., Barlow C.E., Farrell S.W., Vega G.L., Haskell W.L. Cardiorespiratory fitness and metabolic risk. Am. J. Cardiol. 2012, 109:988-993.
59. Lenihan C.R., Taylor C.T. The impact of hypoxia on cell death pathways. Biochem. Soc. Trans. 2013, 41:657-663.
60. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 1995, 289-300.